324 filings
Page 5 of 17
8-K
pgbvqvzgmv3mkxv
9 Feb 21
Brooklyn ImmunoTherapeutics Announces Initiation of Phase 2 Trial of IRX-2 in Combination with Pembrolizumab and Chemotherapy in Triple Negative Breast Cancer
4:32pm
8-K
6j2hlfun7rkkc
4 Feb 21
NTN Buzztime Announces Date of Special Meeting of Stockholders
12:00am
8-K
5f5qnub6fmns
15 Jan 21
NTN Buzztime, Inc. Receives Noncompliance Notice from NYSE American
5:22pm
8-K
qo8wxtuat94963vp
23 Nov 20
Entry into a Material Definitive Agreement
7:02am
8-K
g16mvhqacreb8
13 Nov 20
NTN Buzztime, Inc. Reports Third Quarter 2020 Results
6:35am
8-K
coxvqo77
5 Nov 20
Changes in Registrant's Certifying Accountant
8:00am
8-K
tkoxtbl4zvoh2ql
18 Sep 20
NTN Buzztime Enters Asset Purchase Agreement
5:19pm
8-K
9w3h7k7boxerkiarpv9
14 Aug 20
Entry into a Material Definitive Agreement
5:16pm
8-K
ignuxj bcla
13 Aug 20
Enter into Definitive Merger Agreement
6:05am
8-K
jwcms
12 Aug 20
NTN Buzztime, Inc. Receives Noncompliance Notice from NYSE American
4:55pm
8-K
xrb6krrf
7 Aug 20
NTN Buzztime, Inc. Reports Second Quarter 2020 Results
6:40am
8-K
y8ism 1l16
1 Jul 20
Termination of a Material Definitive Agreement
8:00am
8-K
4303c3eq9bguptjg
17 Jun 20
Other Events
6:30am
8-K
oochyvoeo31tcz0 bs
15 Jun 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
h8bxl4k 6dyf
2 Jun 20
Departure of Directors or Certain Officers
4:30pm
8-K
7pgu5tq9ljn jn
19 May 20
NTN Buzztime, Inc. Reports First Quarter 2020 Results
4:10pm
8-K
sa4kq
21 Apr 20
Entry into a Material Definitive Agreement
4:15pm
8-K
q9kd7e1ggp wtgc
3 Apr 20
Departure of Directors or Certain Officers
4:10pm
8-K
pqaysdsuy936fmf ojls
30 Mar 20
NTN Buzztime, Inc. Receives Noncompliance Notice from NYSE American
4:15pm
8-K
ou6rcr
17 Mar 20
NTN Buzztime, Inc. Reports Fourth Quarter and Full Year 2019 Results
4:20pm